ATXS
Astria Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ATXS Filings
Filing Date
Form Description
Form Type
2025-12-03
Form 425 - Prospectuses and communications, business combinations
Key Events
2025-12-03 · Key Events
Form 425 - Prospectuses and communications, business combinations
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-07
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-05
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-05 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-24
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-10-24 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-10-20
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-20 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-16
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-10-16 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
